financetom
Business
financetom
/
Business
/
BRIEF-Basel Medical Group Prices US $8,820,000 Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Basel Medical Group Prices US $8,820,000 Initial Public Offering
Feb 25, 2025 4:05 PM

Feb 25 (Reuters) - Basel Medical Group Ltd ( BMGL ):

* BASEL MEDICAL GROUP LTD PRICES US$8,820,000 INITIAL PUBLIC

OFFERING

* BASEL MEDICAL GROUP LTD ( BMGL ) -PRICING OF ITS INITIAL PUBLIC

OFFERING

OF 2.2 MILLION ORDINARY SHARES AT PUBLIC OFFERING PRICE OF

US$4.00 PER SHARE

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Enphase Energy (ENPH) Stock Is Popping Off
Why Enphase Energy (ENPH) Stock Is Popping Off
Sep 22, 2024
Enphase Energy Inc ( ENPH ) shares are trading higher by 3.75% to $122.97 Wednesday afternoon after the Federal Reserve cut interest rates by 50 basis points. Why This Matters: Enphase Energy ( ENPH ) is a leading provider of solar energy solutions, particularly microinverters and energy management systems. Solar installations often require significant upfront capital investment, much of which...
BioAge targets to raise up to $142.5 mln in US IPO
BioAge targets to raise up to $142.5 mln in US IPO
Sep 22, 2024
Sept 18 (Reuters) - BioAge Labs said on Wednesday it was aiming to raise as much as $142.5 million in its initial public offering in the United States. ...
Tesla Shares Surge Amid Fed Rate Cut And Cybertruck Developments
Tesla Shares Surge Amid Fed Rate Cut And Cybertruck Developments
Sep 22, 2024
Tesla Inc. ( TSLA ) shares are trading higher Wednesday likely due to the broader market reaction to the Federal Reserve’s recent policy decision to cut interest rates by 50 basis points, marking the first rate cut in over four years. Federal Reserve Update The cutting of the federal funds rate to a range of 4.75%–5% has resonated across multiple...
Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B
Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B
Sep 22, 2024
Organon & Co ( OGN ) has agreed to acquire Roivant Sciences Ltd’s Dermavant Sciences Ltd, which is focused on developing and commercializing therapeutics in immunodermatology. Dermavant’s novel product, Vtama (tapinarof) cream, 1%, for the topical treatment of mild, moderate, and severe plaque psoriasis in adults, was approved by the FDA in May 2022. Vtama cream is a once-daily, steroid-free, topical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved